<DOC>
	<DOCNO>NCT01939548</DOCNO>
	<brief_summary>This study aim evaluate whether PF-02545920 safe effective treatment sub-optimally control symptom schizophrenia 12-week outpatient treatment period . The study use Positive Negative Syndrome Scale ( PANSS ) measure change symptoms PF-02545920 baseline compare placebo .</brief_summary>
	<brief_title>An Outpatient Study Of The Efficacy , Safety , And Tolerability Of PF-02545920 In The Adjunctive Treatment Of Sub-Optimally Controlled Symptoms Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Psychiatrically stable subject schizophrenia suboptimal response current treatment Evidence stable schizophrenia symptomatology great equal 3 month . Subjects must stable medication treatment regimen great equal 2 month , include concomitant psychotropic medication . History seizures condition risk seizure . Subjects schizophrenia respond current treatment . Pregnant nursing female , female child bear potential .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>PF-02545920</keyword>
	<keyword>schizophrenia</keyword>
	<keyword>outpatient</keyword>
	<keyword>safety</keyword>
	<keyword>efficacy</keyword>
	<keyword>suboptimal response</keyword>
</DOC>